Octapharma
Octapharma is the largest privately-owned independent company in the world specializing in plasma fractionation. Their medicines are made from high-quality human proteins derived from blood plasma or produced using recombinant DNA technology. The company develops and manufactures medicines for patients in three treatment areas: hematology, immunotherapy, and intensive care. With offices in 31 countries, their medicines help people in 118 countries worldwide. They operate seven R&D facilities and six production plants in Europe and North America. Their mission is driven by a passion to offer new health solutions that improve human lives, guided by five core values: Ownership, Integrity, Leadership, Sustainability, and Entrepreneurship.
Industries
Nr. of Employees
large (251-1000)
Octapharma
Products
Plasma‑derived human protein therapeutics
Therapeutic proteins and biologic medicines produced from human blood plasma and supplied for treatment in clinical areas including hematology, immunotherapy and intensive care.
Recombinant protein therapeutics
Therapeutic proteins produced using recombinant DNA techniques to provide alternatives or complements to plasma‑derived products.
Plasma‑derived human protein therapeutics
Therapeutic proteins and biologic medicines produced from human blood plasma and supplied for treatment in clinical areas including hematology, immunotherapy and intensive care.
Recombinant protein therapeutics
Therapeutic proteins produced using recombinant DNA techniques to provide alternatives or complements to plasma‑derived products.
Services
Blood bank and plasma collection documentation support
Digital provision of operational templates and forms for blood banks and plasma collection centres, including lookback forms, deviation forms, test certificates and sample label templates.
Global manufacturing and distribution of biologics
Manufacture and international distribution of therapeutic biologic products produced from plasma or via recombinant techniques (service includes production at multiple facilities and international supply).
Blood bank and plasma collection documentation support
Digital provision of operational templates and forms for blood banks and plasma collection centres, including lookback forms, deviation forms, test certificates and sample label templates.
Global manufacturing and distribution of biologics
Manufacture and international distribution of therapeutic biologic products produced from plasma or via recombinant techniques (service includes production at multiple facilities and international supply).
Expertise Areas
- Plasma‑derived therapeutics manufacturing
- Recombinant protein therapeutics development
- Hematology therapeutics
- Immunotherapy therapeutics
Key Technologies
- Plasma fractionation
- Recombinant DNA‑based protein production
- Nucleic acid testing (NAT)
- Biologics purification and downstream processing